Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support for PBM reform. HR 2214 -- "DRUG Act" HR 1492 -- "To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program."
2025 · 1st Quarter (Jan 1 - Mar 31)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
Filed by ADVANCED POLICY CONSULTING, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2025
- Income
- $40,000.00
- Expenses
- Not reported
- Registrant
- ADVANCED POLICY CONSULTING, LLC
- Filing UUID
- 635909d7-18d4-47ff-b9d1-7118e75d4b1f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.